Related Experiment Videos

Methylmalonic acidemia: brain lesions in a case of vitamin B12 non-responsive (mut0) type

K Yamaguchi1, K Hirabayashi, K Honma

  • 1Department of Pediatrics, Higashi-Saitama National Hospital, Japan.

Insights

Neuropathological examination of an infant with vitamin B12 non-responsive methylmalonic acidemia (MMA) revealed widespread cell death and brain lesions. These findings highlight the severe neurological impact of this metabolic disorder.

Area of Science:

  • Neuropathology
  • Metabolic Disorders
  • Neuroscience

Background:

  • Methylmalonic acidemia (MMA) is a group of inherited metabolic disorders.
  • The vitamin B12 non-responsive (mut0) type of MMA presents unique challenges in understanding its pathogenesis.
  • Infants with mut0 MMA often exhibit severe neurological complications.

Observation:

  • A 9-day-old female infant with mut0 MMA exhibited widespread neuropathological changes.
  • Key findings included karyorrhexis (cell fragmentation) in the cerebellum and striate cortex.
  • Necrotic foci were observed in the hippocampus, basal ganglia, thalamus, hypothalamus, brainstem, and cerebral cortex.

Findings:

  • Spongy degeneration of myelinated nerve fibers in the brainstem was noted.
  • Alzheimer type II astrocytes were present in the caudate nucleus.
  • Hemorrhagic foci were predominantly in the cerebellar granular layers, and lymphoid tissues were hypoplastic.

Implications:

  • The study suggests selective karyorrhexis in specific cell types, including immature neurons, in mut0 MMA.
  • While systemic ischemia/hypoxia cannot be ruled out, the findings point to intrinsic cellular mechanisms.
  • Understanding these neuropathological mechanisms is crucial for potential therapeutic strategies in MMA.

Related Concept Videos